2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theOnychomycosis Treatment Market?

The rise in fungal infections is anticipated to boost the onychomycosis treatment market’s expansion. Fungal infections are microbial illnesses caused by a variety of fungi that affect various parts of the body or induce certain conditions. Onychomycosis, a fungal nail infection, is generally treated with oral or topical antifungal medications to eradicate the fungus and promote healthy nail growth. For example, the UK Health Security Agency reported 2,265 cases of bloodstream infections (BSI) due to yeast in England in 2022, according to data from September 2023. The incidence rate of BSI as a result of yeast increased marginally to 4.0 per 100,000 population from 3.8 per 100,000 in 2021. The most frequently identified yeast species in blood samples were Candida albicans (40%), Nakaseomyces glabratus (also known as Candida glabrata, 29%), and Candida parapsilosis (13%). Thus, the rise in fungal infections is stimulating the onychomycosis treatment market’s growth.

Diabetes Prevalence is Fuelling the Onychomycosis Treatment Market’s Growth

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

#What is the Anticipated CAGR of theOnychomycosis Treatment Market, and What Factors Will Drive It?

The market for onychomycosis treatments has seen robust growth in recent years. The market size will expand from $3.65 billion in 2024 to $3.92 billion in 2025, registering a compound annual growth rate (CAGR) of 7.4%. The historical growth can be credited to an uptick in fungal infections, an aging demographic, heightened public awareness, an increase in onychomycosis cases, and growth in disposable income.

There is an expectation for the onychomycosis treatment market size to experience robust growth in the upcoming years. Predictions have placed its value at $5.09 billion come 2029, with a compound annual growth rate (CAGR) of 6.7%. The predicted growth in the stated forecast period can be linked to several factors. These include an aging demographic, the proliferation of telemedicine, the advent of combination therapies, improved access to healthcare, lifestyle and environmental changes, and a rise in diabetes prevalence. Key trends for the forecast period encompass progress in dermatology, innovation in drug delivery, bespoke treatment plans, advancements in topical treatments, integration of digital health solutions and the advent of laser therapy.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12941

Which Upcoming Market Trends and Innovations Are Set to Influence theOnychomycosis Treatment Market’s Path Forward?

In the onychomycosis treatment market, key players are focusing their efforts on the development and approval of fresh products like MOB-015 to secure a market advantage. For example, Moberg Pharma AB, a pharmaceutical firm based in Sweden, gained European Union approval for MOB-015 in June 2023. This approval, intended for treating mild to moderate nail fungal infections in adults, represents the innovative onychomycosis drug’s inaugural authorization for global marketing. The approval of MOB-015 was supported by two Phase 3 trials which showcased a better mycological cure rate (76% versus a maximum of 42% for comparators) and a significantly higher total cure rate than the control group, without any severe side effects occurring. MOB-015, a topical terbinafine formulation, ensures effective terbinafine concentrations reach the nail and nail bed, eliminating the systemic exposure risk associated with orally administered terbinafine treatment.

Who Are the Dominant Market Players Pushing the Boundaries of theOnychomycosis Treatment Market?

Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd., Nuray Chemicals Private Limited.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

What Are the Core Segments of the Onychomycosis Treatment Market, and How Do They Contribute to Growth?

The onychomycosis treatment market covered in this report is segmented –

1) By Type: Distal Sublingual Onychomycosis, White Superficial Onychomycosis, Proximal Sublingual Onychomycosis, Candida Onychomycosis, Other Types

2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy

3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12941&type=smp

What Regions Are Dominating the Onychomycosis Treatment Market Growth?

North America was the largest region in the onychomycosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onychomycosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2025, By The Business Research Company:

Biopharmaceuticals Contract Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Mid-Size Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/mid-size-pharmaceuticals-global-market-report

Generic Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: